To the Editor We read with interest the results of phase 2 of the CAIRO6 trial that showed the feasibility and safety of perioperative chemotherapy in patients with resectable colorectal peritoneal metastases (CPM). The major postoperative morbidity was similar in both arms, although the absolute figures showed a lower morbidity in the experimental arm (22% vs 33% in the control arm).

中文翻译：

---

CAIRO6 试验对结直肠腹膜转移瘤治疗的新见解

致编辑 我们感兴趣地阅读了 CAIRO6 试验的 2 期结果，该试验表明围手术期化疗对可切除结直肠腹膜转移 (CPM) 患者的可行性和安全性。两组的主要术后发病率相似，尽管绝对数据显示实验组的发病率较低（22% vs 对照组 33%）。